Tazolol

Tazolol
Klinički podaci
Identifikatori
CAS broj	39832-48-9
ATC kod	nije dodeljen
PubChem	71721
ChemSpider	64770
UNII	B64Q38TX4G
Hemijski podaci
Formula	C9H16N2O2S
Mol. masa	216,30054
SMILES	eMolekuli & PubHem
InChI
	InChI=DREVJBVJBRSSDL-UHFFFAOYSA-N ; Key: DREVJBVJBRSSDL-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Tazolol je beta blokator sa mogućom primenom u tretmanu srčanih bolesti.^[4]

Hemijska sinteza

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Strosberg AM. (1976). „The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant”. Arch Int Pharmacodyn Ther. 222 (2): 200-15.

	Portal Medicina
	Portal Hemija